Le Lézard
Classified in: Business
Subject: LAW

Halunen Law Wins $4.6 Million Verdict On Behalf of Client in Whistleblower Case


In a landmark whistleblower case in Minnesota, a highly regarded former radiologist attains justice following wrongful termination for bringing safety concerns to light

MINNEAPOLIS, Jan. 23, 2024 /PRNewswire/ -- A board-certified radiologist, senior shareholder, and employee of Consulting Radiologist Limited (CRL) was awarded $4.6 million in damages by a Hennepin County jury for being wrongfully terminated under Minnesota's whistleblower protection law. Halunen Law of Minneapolis, Minnesota, represented the plaintiff in this landmark trial. CRL contracts to provide services to Allina Health, including Abbott Northwestern, in the Twin Cities metro area. 

After nearly 20 years with CRL as a board-certified radiologist, and senior shareholder, the plaintiff was deeply invested in CRL's future success. As such, in good faith, he brought forth patient safety concerns to the company's leadership. When the CRL board repeatedly failed to act, the plaintiff warned that if the unsafe and unethical practices continued, he would have no choice but to report his concerns to Allina Health, the parent company of Abbott Northwestern Hospital. Days after affirming his commitment to share his concerns with Allina Health, he was subsequently terminated by the CRL Board of Directors. As a result of his termination, the plaintiff lost his radiologist position and his livelihood. 

The two-week-long trial and deliberation resulted in a jury verdict, finding the plaintiff was terminated in violation of the Minnesota Whistleblower Act. The jury awarded him damages for past and future wage loss and emotional distress, totaling $4,587,602.

Attorney Pamela Johnson, one of Halunen Law's senior trial attorneys representing the plaintiff, commented: "Today we sent a message. This jury understood the serious nature of Defendant CRL's conduct and held it accountable in a big way. This is one of the largest whistleblower verdicts ever in Minnesota. It should be a warning to all Minnesota employers that if you retaliate against employees who stand up to expose safety concerns, you will be held accountable." 

About Halunen Law: With offices in Minneapolis and Chicago, Halunen Law offers experienced legal representation to employees and whistleblowers nationwide. Halunen Law has achieved a reputation as a fearless, tenacious, and successful plaintiffs' law firm with a laser focus on achieving justice and meaningful results for its clients. More information at halunenlaw.com.

For further information contact:
Carol Schuler, Schuler Publicity
612-281-7030 | [email protected]

SOURCE Halunen Law


These press releases may also interest you

at 03:24
Day 1 of the London Blockchain Conference kicks off today with world-renowned marketing and business entrepreneur and professor Scott Galloway taking the stage.   Tech influencer Lilly Douse will also host this year's conference. She will bring her...

at 03:22
Sungrow, the global leading PV inverter and energy storage system provider, has forged a strategic partnership with Larsen & Toubro to supply 165MW PV inverters and 160MW/760MWh energy storage systems for AMAALA, a prestigious destination in Saudi...

at 03:14
Allied Market Research published a report, titled, "Managed Learning Service Market by Type (Sourcing External Training, L&D Administration, Supplier Management, and Others), Enterprise Size (Small & Medium Enterprises and Large Enterprises),...

at 03:03
Configit, a global leader in Configuration Lifecycle Management (CLM), today announced that Knauf Digital GmbH, a subsidiary of the Knauf Group, has implemented Configit Ace® SaaS to accelerate its Configure, Price, Quote (CPQ) process. Configit's...

at 03:01
Today sees the launch of the Leandro Herrero Institute; a membership community for leaders and professionals who want to directly benefit from Leandro's unique experience, expertise and insights. This was gained from his 25+ years pioneering a better...

at 03:00
Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide range of hard-to-treat cancers, today announces the completion of a $120m Series B financing to fund the development of its...



News published on and distributed by: